Isagenix International has received a $35 million investment from its co-founders Jim and Kathy Coover and Chief Visionary Officer Erik Coover—the controlling shareholders—as well as from minority shareholders Jim and Tammy Pierce. Combined with additional funds from Isagenix, the investment has enabled the company to retire over $60 million of the principal amount of the company’s debt and to further support its current growth trends and expanding operations. According to Jim Coover, he and his family are optimistic about the future of the company and wanted to further demonstrate their commitment to its success. The investment will also support the momentum of Isagenix as it brings more products and technology solutions to the market. Since January, the Isagenix customer base has increased by 45 percent, and it has expanded its reach to 26 markets across the globe. In addition to the investment, the company’s lending partners have reconfirmed their support for the business with an amendment to their credit agreement, which will give the company greater flexibility for growth.